ArticleScientific reports2025
AI-driven antimicrobial peptide characterization unveils novel motifs for drug design.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Marine Antimicrobial Peptides: From Ocean Biodiversity to Genome Mining, Multi-Omics Discovery, and Biotechnological Innovation in the Battle Against Antimicrobial Resistance.Probiotics and antimicrobial proteins · 2026Review
- Natural and Synthetic AMPs from Latin America across Diversity Engineering and Applications.ACS infectious diseases · 2026Review
- Integrative computational-experimental discovery and translation of antifungal peptides for multidrug-resistant fungi.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Antibiotics have been developed to effectively target and eliminate bacteria, but the rise in antimicrobial resistance (AR) complicates the treatment of certain infections. To address this issue, researchers have explored antimicrobial peptides (AMPs) that disrupt bacterial membranes. A promising method for this exploration is motif-based analysis, which identifies hidden patterns in AMPs to better understand their mechanism of action. While existing methods rely on expert knowledge, incorporating topic models can enhance analysis by revealing the contextual relationships between sequence elements. This is complemented by a data analytics tool designed to analyze AMP motifs and their biochemical properties. Such integration allows for the extraction of valuable motifs and the development of a robust data analytics module for predicting membrane activity. Additionally, we evaluated the biological relevance of motifs by extracting biochemical features, making structural predictions via Evolutionary Scale Modeling (ESM). Our results indicate that topic model-derived motifs are strongly associated with antimicrobial activity and demonstrate lower minimum inhibitory concentration values and capture contextual information more effectively than traditional frequency-based motifs. We also performed a comparative analysis between the two approaches regarding motif evolution, sequence-level attributes, and entropy measures, ultimately contributing to ongoing efforts to combat AR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.